Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.

Gao J, Wang H, Sheng H, Lynch JR, Warner DS, Durham L, Vitek MP, Laskowitz DT.

Neurocrit Care. 2006;4(1):25-31.

PMID:
16498192
2.

Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage.

Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, Warner DS, Laskowitz DT.

Neurosurg Focus. 2006 Sep 15;21(3):E4.

PMID:
17029343
3.

Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.

Lin CL, Dumont AS, Calisaneller T, Kwan AL, Hwong SL, Lee KS.

Surg Neurol. 2005 Sep;64(3):201-5; discussion 205-6.

PMID:
16099244
4.

Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.

Han BH, Vellimana AK, Zhou ML, Milner E, Zipfel GJ.

Neurosurgery. 2012 Jan;70(1):178-86; discussion 186-7. doi: 10.1227/NEU.0b013e31822ec2b0.

5.

Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.

Pradilla G, Garzon-Muvdi T, Ruzevick JJ, Bender M, Edwards L, Momin EN, Thompson RC, Tamargo RJ.

Neurosurgery. 2012 Mar;70(3):747-56; discussion 756-7. doi: 10.1227/NEU.0b013e3182363c2f.

PMID:
21915076
6.

Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm.

Vellimana AK, Milner E, Azad TD, Harries MD, Zhou ML, Gidday JM, Han BH, Zipfel GJ.

Stroke. 2011 Mar;42(3):776-82. doi: 10.1161/STROKEAHA.110.607200. Epub 2011 Feb 11.

8.

Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.

Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.

J Neurosurg. 2016 Jan;124(1):51-8. doi: 10.3171/2014.12.JNS13846. Epub 2015 Jul 10.

PMID:
26162034
9.

A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

Garzon-Muvdi T, Pradilla G, Ruzevick JJ, Bender M, Edwards L, Grossman R, Zhao M, Rudek MA, Riggins G, Levy A, Tamargo RJ.

Neurosurgery. 2013 Oct;73(4):719-28; discussion 729. doi: 10.1227/NEU.0000000000000080. Erratum in: Neurosurgery. 2013 Dec;73(6):E1098.

10.

Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.

Momin EN, Schwab KE, Chaichana KL, Miller-Lotan R, Levy AP, Tamargo RJ.

Neurosurgery. 2009 Nov;65(5):937-45; discussion 945. doi: 10.1227/01.NEU.0000356974.14230.B8.

PMID:
19834407
11.

Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.

Grootendorst J, Bour A, Vogel E, Kelche C, Sullivan PM, Dodart JC, Bales K, Mathis C.

Behav Brain Res. 2005 Apr 15;159(1):1-14. Epub 2004 Nov 6.

PMID:
15794991
12.

APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.

Lanterna LA, Rigoldi M, Tredici G, Biroli F, Cesana C, Gaini SM, Dalprà L.

Neurology. 2005 Apr 12;64(7):1238-44.

PMID:
15824354
13.

Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.

Wang H, Gao J, Lassiter TF, McDonagh DL, Sheng H, Warner DS, Lynch JR, Laskowitz DT.

Neurocrit Care. 2006;5(1):71-8.

PMID:
16960300
14.

Effect of raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats.

Gulsen S, Inci S, Yuruk S, Yasar U, Ozgen T.

Neurol Med Chir (Tokyo). 2007 Dec;47(12):537-42; discussion 542.

15.

A low mortality rat model to assess delayed cerebral vasospasm after experimental subarachnoid hemorrhage.

Dudhani RV, Kyle M, Dedeo C, Riordan M, Deshaies EM.

J Vis Exp. 2013 Jan 17;(71):e4157. doi: 10.3791/4157.

16.

A murine model of subarachnoid hemorrhage-induced cerebral vasospasm.

Lin CL, Calisaneller T, Ukita N, Dumont AS, Kassell NF, Lee KS.

J Neurosci Methods. 2003 Feb 15;123(1):89-97.

PMID:
12581852
17.

Prevention of cerebral vasospasm by a capsaicin derivative, glyceryl nonivamide, in an experimental model of subarachnoid hemorrhage.

Lin CL, Lo YC, Chang CZ, Kwan AL, Chen IJ, Howng SL.

Surg Neurol. 2001 May;55(5):297-301.

PMID:
11516473
18.

Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.

Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K.

J Neurosurg. 2014 Sep;121(3):621-30. doi: 10.3171/2014.5.JNS132140. Epub 2014 Jun 20.

PMID:
24949677
19.

Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.

Sheng H, Laskowitz DT, Bennett E, Schmechel DE, Bart RD, Saunders AM, Pearlstein RD, Roses AD, Warner DS.

J Cereb Blood Flow Metab. 1998 Apr;18(4):361-6.

PMID:
9538900
20.

CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage.

Laslo AM, Eastwood JD, Pakkiri P, Chen F, Lee TY.

AJNR Am J Neuroradiol. 2008 Jan;29(1):79-85. Epub 2007 Oct 26.

Supplemental Content

Support Center